CAR-T cells: Early successes in blood cancer and challenges in solid tumors

New approaches to cancer immunotherapy have been developed, showing the ability to harness the immune system to treat and eliminate cancer. For many solid tumors, therapy with checkpoint inhibitors has shown promise. For hematologic malignancies, adoptive and engineered cell therapies are being wide...

Descripción completa

Detalles Bibliográficos
Autores principales: Dana, Hassan, Chalbatani, Ghanbar Mahmoodi, Jalali, Seyed Amir, Mirzaei, Hamid Reza, Grupp, Stephan A., Suarez, Eloah Rabello, Rapôso, Catarina, Webster, Thomas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144892/
https://www.ncbi.nlm.nih.gov/pubmed/34094824
http://dx.doi.org/10.1016/j.apsb.2020.10.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144892/
https://www.ncbi.nlm.nih.gov/pubmed/34094824
http://dx.doi.org/10.1016/j.apsb.2020.10.020

Ejemplares similares